Q1 2025 Holdings
Filed 2025-05-15 | 32 holdings | $188.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $14.9M | 370,000 | 7.9% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $11.7M | 1,014,367 | 6.2% |
| Evolus Inc(EOLS) | COM | 30052C107 | $11.4M | 944,743 | 6.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $10.2M | 1,638,111 | 5.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $10.1M | 750,000 | 5.4% |
| Merus N V | COM | N5749R100 | $10.0M | 237,156 | 5.3% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $9.5M | 4,973,840 | 5.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $8.2M | 245,272 | 4.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $7.8M | 50,000 | 4.1% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $7.7M | 595,879 | 4.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $7.5M | 250,000 | 4.0% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $6.4M | 1,811,996 | 3.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $6.4M | 375,000 | 3.4% |
| Unicycive Therapeutics Inc | COM | 90466Y103 | $6.3M | 10,980,000 | 3.3% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $5.5M | 470,964 | 2.9% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $5.0M | 275,000 | 2.6% |
| Summit Therapeutics Inc(SMMT)Put | COM | 86627T108 | $4.8M | 250,000 | 2.6% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $4.7M | 138,240 | 2.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $4.4M | 115,517 | 2.3% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $4.2M | 2,728,910 | 2.2% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $4.2M | 373,833 | 2.2% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $4.1M | 3,170,194 | 2.2% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $3.4M | 175,562 | 1.8% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $3.0M | 45,000 | 1.6% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $2.9M | 1,275,000 | 1.5% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $2.9M | 4,683,711 | 1.5% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $2.4M | 833,042 | 1.3% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $2.2M | 149,702 | 1.1% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $2.1M | 626,275 | 1.1% |
| Promis Neurosciences Inc(PMNEUR) | COM NEW | 74346M406 | $1.8M | 2,645,128 | 1.0% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $1.8M | 300,000 | 1.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $1.1M | 850,000 | 0.6% |